Other Species / Isoforms
  HuR (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MsNGyEDHM
0 9
HuR (human) ______MsNGyEDHM S2-p
HuR iso2 (human) RFLKNTMSNGYEDHM S29
HuR (mouse) ______MsNGyEDHM S2-p
HuR (rat) ______MSNGYEDHM S2
Y5-p
___MsNGyEDHMAED
0 3
HuR (human) ___MsNGyEDHMAED Y5-p
HuR iso2 (human) KNTMSNGYEDHMAED Y32
HuR (mouse) ___MsNGyEDHMAED Y5-p
HuR (rat) ___MSNGYEDHMAED Y5
R14-m1
DHMAEDCrGDIGRTN
0 1
HuR (human) DHMAEDCrGDIGRTN R14-m1
HuR iso2 (human) DHMAEDCRGDIGRTN R41
HuR (mouse) DHMAEDCRDDIGRTN R14
HuR (rat) DHMAEDCRDDIGRTN R14
Y26-p
RTNLIVNyLPQNMtQ
0 5
HuR (human) RTNLIVNyLPQNMtQ Y26-p
HuR iso2 (human) RTNLIVNYLPQNMTQ Y53
HuR (mouse) RTNLIVNYLPQNMTQ Y26
HuR (rat) RTNLIVNYLPQNMTQ Y26
T32-p
NyLPQNMtQDELRsL
0 3
HuR (human) NyLPQNMtQDELRsL T32-p
HuR iso2 (human) NYLPQNMTQDELRSL T59
HuR (mouse) NYLPQNMTQEELRSL T32
HuR (rat) NYLPQNMTQEELRSL T32
S38-p
MtQDELRsLFsSIGE
0 1
HuR (human) MtQDELRsLFsSIGE S38-p
HuR iso2 (human) MTQDELRSLFSSIGE S65
HuR (mouse) MTQEELRSLFSSIGE S38
HuR (rat) MTQEELRSLFSSIGE S38
S41-p
DELRsLFsSIGEVEs
0 1
HuR (human) DELRsLFsSIGEVEs S41-p
HuR iso2 (human) DELRSLFSSIGEVES S68
HuR (mouse) EELRSLFSSIGEVES S41
HuR (rat) EELRSLFSSIGEVES S41
S48-p
sSIGEVEsAkLIRDk
0 2
HuR (human) sSIGEVEsAkLIRDk S48-p
HuR iso2 (human) SSIGEVESAKLIRDK S75
HuR (mouse) SSIGEVESAkLIRDk S48
HuR (rat) SSIGEVESAKLIRDK S48
K50-ub
IGEVEsAkLIRDkVA
0 18
HuR (human) IGEVEsAkLIRDkVA K50-ub
HuR iso2 (human) IGEVESAKLIRDKVA K77
HuR (mouse) IGEVESAkLIRDkVA K50-ub
HuR (rat) IGEVESAKLIRDKVA K50
K55-ub
sAkLIRDkVAGHSLG
0 11
HuR (human) sAkLIRDkVAGHSLG K55-ub
HuR iso2 (human) SAKLIRDKVAGHSLG K82
HuR (mouse) SAkLIRDkVAGHSLG K55-ub
HuR (rat) SAKLIRDKVAGHSLG K55
Y63-p
VAGHSLGyGFVNyVT
Upstream
1 3
Kinase, in vitro:
  • JAK3 (human)
HuR (human) VAGHSLGyGFVNyVT Y63-p
HuR iso2 (human) VAGHSLGYGFVNYVT Y90
HuR (mouse) VAGHSLGYGFVNYVT Y63
HuR (rat) VAGHSLGYGFVNYVT Y63
Y68-p
LGyGFVNyVTAkDAE
Upstream
1 2
Kinase, in vitro:
  • JAK3 (human)
HuR (human) LGyGFVNyVTAkDAE Y68-p
HuR iso2 (human) LGYGFVNYVTAKDAE Y95
HuR (mouse) LGYGFVNYVTAkDAE Y68
HuR (rat) LGYGFVNYVTAKDAE Y68
K72-ub
FVNyVTAkDAERAIN
0 18
HuR (human) FVNyVTAkDAERAIN K72-ub
HuR iso2 (human) FVNYVTAKDAERAIN K99
HuR (mouse) FVNYVTAkDAERAIs K72-ub
HuR (rat) FVNYVTAKDAERAIS K72
K72-sc
FVNyVTAkDAERAIN
0 1
HuR (human) FVNyVTAkDAERAIN K72-sc
HuR iso2 (human) FVNYVTAKDAERAIN K99
HuR (mouse) FVNYVTAKDAERAIs K72
HuR (rat) FVNYVTAKDAERAIS K72
N79
kDAERAINtLNGLRL
0 1
HuR (human) kDAERAINtLNGLRL N79
HuR iso2 (human) KDAERAINTLNGLRL N106
HuR (mouse) kDAERAIstLNGLRL S79-p
HuR (rat) KDAERAISTLNGLRL S79
T80-p
DAERAINtLNGLRLQ
0 2
HuR (human) DAERAINtLNGLRLQ T80-p
HuR iso2 (human) DAERAINTLNGLRLQ T107
HuR (mouse) DAERAIstLNGLRLQ T80-p
HuR (rat) DAERAISTLNGLRLQ T80
S88-p
LNGLRLQskTIkVSY
Upstream
Downstream
4 0
Effects on Modified Protein
  • molecular association, regulation
  • protein degradation
Effects on Biological Processes:
  • RNA splicing, induced
  • RNA stability, altered
Kinase, in vitro:
  • Chk2 (human)
Putative in vivo kinases:
  • Chk2 (human)
  • P38A (human)
Treatment
  • arsenite
  • Chk2_inhibitor_II
  • H2O2
  • siRNA
HuR (human) LNGLRLQskTIkVSY S88-p
HuR iso2 (human) LNGLRLQSKTIKVSY S115
HuR (mouse) LNGLRLQSKTIkVSY S88
HuR (rat) LNGLRLQSKTIKVSY S88
K89-ub
NGLRLQskTIkVSYA
0 2
HuR (human) NGLRLQskTIkVSYA K89-ub
HuR iso2 (human) NGLRLQSKTIKVSYA K116
HuR (mouse) NGLRLQSKTIkVSYA K89
HuR (rat) NGLRLQSKTIKVSYA K89
K92-ub
RLQskTIkVSYARPS
0 4
HuR (human) RLQskTIkVSYARPS K92-ub
HuR iso2 (human) RLQSKTIKVSYARPS K119
HuR (mouse) RLQSKTIkVSYARPS K92-ub
HuR (rat) RLQSKTIKVSYARPS K92
S100-p
VSYARPSsEVIkDAN
Upstream
Downstream
5 2
Effects on Modified Protein
  • molecular association, regulation
  • protein degradation
Effects on Biological Processes:
  • RNA splicing, induced
  • RNA stability, altered
  • translation, induced
Kinase, in vitro:
  • Akt1 (human)
  • Chk2 (human)
Putative in vivo kinases:
  • Akt1 (human)
  • Chk2 (human)
Treatment
  • Chk2_inhibitor_II
  • H2O2
  • siRNA
HuR (human) VSYARPSsEVIkDAN S100-p
HuR iso2 (human) VSYARPSSEVIKDAN S127
HuR (mouse) VSYARPSSEVIkDAN S100
HuR (rat) VSYARPSSEVIKDAN S100
K104-ub
RPSsEVIkDANLyIs
0 8
HuR (human) RPSsEVIkDANLyIs K104-ub
HuR iso2 (human) RPSSEVIKDANLYIS K131
HuR (mouse) RPSSEVIkDANLYIS K104-ub
HuR (rat) RPSSEVIKDANLYIS K104
Y109-p
VIkDANLyIsGLPRT
0 6
HuR (human) VIkDANLyIsGLPRT Y109-p
HuR iso2 (human) VIKDANLYISGLPRT Y136
HuR (mouse) VIkDANLYISGLPRT Y109
HuR (rat) VIKDANLYISGLPRT Y109
S111-p
kDANLyIsGLPRTMt
0 2
HuR (human) kDANLyIsGLPRTMt S111-p
HuR iso2 (human) KDANLYISGLPRTMT S138
HuR (mouse) kDANLYISGLPRTMT S111
HuR (rat) KDANLYISGLPRTMT S111
T118-p
sGLPRTMtQkDVEDM
Upstream
Downstream
7 3
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • RNA splicing, induced
  • RNA stability, altered
  • RNA stability, induced
  • transcription, induced
Kinase, in vitro:
  • Chk2 (human)
  • P38A (human)
Putative in vivo kinases:
  • Chk2 (human)
  • P38A (human)
Treatment
  • arsenite
  • H2O2
  • heat_shock
  • ionizing_radiation
  • MKK6DD
  • SB203580
  • siRNA
HuR (human) sGLPRTMtQkDVEDM T118-p
HuR iso2 (human) SGLPRTMTQKDVEDM T145
HuR (mouse) SGLPRTMTQkDVEDM T118
HuR (rat) SGLPRTMTQKDVEDM T118
K120-ub
LPRTMtQkDVEDMFS
0 8
HuR (human) LPRTMtQkDVEDMFS K120-ub
HuR iso2 (human) LPRTMTQKDVEDMFS K147
HuR (mouse) LPRTMTQkDVEDMFS K120-ub
HuR (rat) LPRTMTQKDVEDMFS K120
T143-p
RVLVDQTtGLsrGVA
0 1
HuR (human) RVLVDQTtGLsrGVA T143-p
HuR iso2 (human) RVLVDQTTGLSRGVA T170
HuR (mouse) RVLVDQTTGLSRGVA T143
HuR (rat) RVLVDQTTGLSRGVA T143
S146-p
VDQTtGLsrGVAFIR
0 1
HuR (human) VDQTtGLsrGVAFIR S146-p
HuR iso2 (human) VDQTTGLSRGVAFIR S173
HuR (mouse) VDQTTGLSRGVAFIR S146
HuR (rat) VDQTTGLSRGVAFIR S146
R147-m1
DQTtGLsrGVAFIRF
0 4
HuR (human) DQTtGLsrGVAFIRF R147-m1
HuR iso2 (human) DQTTGLSRGVAFIRF R174
HuR (mouse) DQTTGLSRGVAFIRF R147
HuR (rat) DQTTGLSRGVAFIRF R147
S158-p
FIRFDKRsEAEEAIT
Upstream
Downstream
3 0
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • RNA stability, altered
  • translation, altered
Kinase, in vitro:
  • PKCA (human)
Treatment
  • CG-5
HuR (human) FIRFDKRsEAEEAIT S158-p
HuR iso2 (human) FIRFDKRSEAEEAIT S185
HuR (mouse) FIRFDKRSEAEEAIT S158
HuR (rat) FIRFDKRSEAEEAIT S158
K171-ub
ITSFNGHkPPGSSEP
0 1
HuR (human) ITSFNGHkPPGSSEP K171-ub
HuR iso2 (human) ITSFNGHKPPGSSEP K198
HuR (mouse) ITSFNGHKPPGSSEP K171
HuR (rat) ITSFNGHKPPGSSEP K171
K182-ub
SSEPITVkFAANPNQ
Upstream
Downstream
3 2
Effects on Modified Protein
  • molecular association, regulation
  • protein degradation
Regulatory protein:
  • SPINK7 (human)
Treatment
  • heat_shock
HuR (human) SSEPITVkFAANPNQ K182-ub
HuR iso2 (human) SSEPITVKFAANPNQ K209
HuR (mouse) SSEPITVKFAANPNQ K182
HuR (rat) SSEPITVKFAANPNQ K182
K191-ub
AANPNQNkNVALLsQ
0 22
HuR (human) AANPNQNkNVALLsQ K191-ub
HuR iso2 (human) AANPNQNKNVALLSQ K218
HuR (mouse) AANPNQNkNMALLSQ K191-ub
HuR (rat) AANPNQNKNMALLSQ K191
S197-p
NkNVALLsQLyHsPA
0 13
HuR (human) NkNVALLsQLyHsPA S197-p
HuR iso2 (human) NKNVALLSQLYHSPA S224
HuR (mouse) NkNMALLSQLyHsPA S197
HuR (rat) NKNMALLSQLYHsPA S197
Y200-p
VALLsQLyHsPArrF
Upstream
Downstream
1 241
Effects on Modified Protein
  • intracellular localization
Kinase, in vitro:
  • JAK3 (human)
Treatment
  • nocodazole
HuR (human) VALLsQLyHsPArrF Y200-p
HuR iso2 (human) VALLSQLYHSPARRF Y227
HuR (mouse) MALLSQLyHsPARrF Y200-p
HuR (rat) MALLSQLYHsPARrF Y200
S202-p
LLsQLyHsPArrFGG
Upstream
Downstream
8 117
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • RNA stability, inhibited
  • apoptosis, induced
  • cell cycle regulation
  • translation, inhibited
Kinase, in vitro:
  • CDK1 (human)
  • CDK2 (human)
  • CDK5 (human)
  • CDK6 (human)
Putative in vivo kinases:
  • CDK1 (human)
  • CDK5 (human)
  • CDK6 (human)
Regulatory protein:
  • BAG3 (human)
Treatment
  • alsterpaullone
  • aphidicolin
  • BI_4834
  • CGP74514A
  • metastatic potential
  • nocodazole
  • siRNA
  • thymidine
HuR (human) LLsQLyHsPArrFGG S202-p
HuR iso2 (human) LLSQLYHSPARRFGG S229
HuR (mouse) LLSQLyHsPARrFGG S202-p
HuR (rat) LLSQLYHsPARrFGG S202-p
R205-m1
QLyHsPArrFGGPVH
0 7
HuR (human) QLyHsPArrFGGPVH R205-m1
HuR iso2 (human) QLYHSPARRFGGPVH R232
HuR (mouse) QLyHsPARrFGGPVH R205
HuR (rat) QLYHsPARrFGGPVH R205
R206-m1
LyHsPArrFGGPVHH
0 42
HuR (human) LyHsPArrFGGPVHH R206-m1
HuR iso2 (human) LYHSPARRFGGPVHH R233
HuR (mouse) LyHsPARrFGGPVHH R206-m1
HuR (rat) LYHsPARrFGGPVHH R206-m1
R206
LyHsPArRFGGPVHH
0 2
HuR (human) LyHsPArRFGGPVHH R206
HuR iso2 (human) LYHSPARRFGGPVHH R233
HuR (mouse) LyHsPARrFGGPVHH R206-m2
HuR (rat) LYHsPARRFGGPVHH R206
R217-me
PVHHQAQrFrFsPMG
Upstream
Downstream
2 0
Effects on Biological Processes:
  • RNA stability, altered
Treatment
  • LPS
HuR (human) PVHHQAQrFrFsPMG R217-me
HuR iso2 (human) PVHHQAQRFRFSPMG R244
HuR (mouse) PVHHQAQRFrFsPMG R217
HuR (rat) PVHHQAQRFRFSPMG R217
R217-m1
PVHHQAQrFrFsPMG
0 50
HuR (human) PVHHQAQrFrFsPMG R217-m1
HuR iso2 (human) PVHHQAQRFRFSPMG R244
HuR (mouse) PVHHQAQrFrFsPMG R217-m1
HuR (rat) PVHHQAQrFRFSPMG R217-m1
R217-m2
PVHHQAQrFrFsPMG
0 12
HuR (human) PVHHQAQrFrFsPMG R217-m2
HuR iso2 (human) PVHHQAQRFRFSPMG R244
HuR (mouse) PVHHQAQrFrFsPMG R217-m2
HuR (rat) PVHHQAQRFRFSPMG R217
R219-m1
HHQAQrFrFsPMGVD
0 4
HuR (human) HHQAQrFrFsPMGVD R219-m1
HuR iso2 (human) HHQAQRFRFSPMGVD R246
HuR (mouse) HHQAQrFrFsPMGVD R219-m1
HuR (rat) HHQAQrFRFSPMGVD R219
R219-m2
HHQAQrFrFsPMGVD
0 1
HuR (human) HHQAQrFrFsPMGVD R219-m2
HuR iso2 (human) HHQAQRFRFSPMGVD R246
HuR (mouse) HHQAQrFRFsPMGVD R219
HuR (rat) HHQAQrFRFSPMGVD R219
S221-p
QAQrFrFsPMGVDHM
Upstream
Downstream
11 0
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • RNA stability, altered
  • RNA stability, induced
  • apoptosis, induced
  • cell motility, altered
  • translation, altered
Kinase, in vitro:
  • PKCA (human)
  • PKCD (human)
Putative in vivo kinases:
  • JNK1 (human)
  • PKCD (human)
Regulatory protein:
  • NOX4 (human)
  • SIDT2 (human)
Treatment
  • adriamycin
  • angiotensin_2
  • CG-5
  • chloroquine
  • docetaxel
  • siRNA
  • SP600125
HuR (human) QAQrFrFsPMGVDHM S221-p
HuR iso2 (human) QAQRFRFSPMGVDHM S248
HuR (mouse) QAQrFrFsPMGVDHM S221-p
HuR (rat) QAQrFRFSPMGVDHM S221
S242-p
NVPGNASsGWCIFIY
Downstream
2 0
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
  • cell growth, altered
HuR (human) NVPGNASsGWCIFIY S242-p
HuR iso2 (human) NVPGNASSGWCIFIY S269
HuR (mouse) NVPGNASSGWCIFIY S242
HuR (rat) NVPGNASSGWCIFIY S242
K283-ub
IRDFNTNkCKGFGFV
0 6
HuR (human) IRDFNTNkCKGFGFV K283-ub
HuR iso2 (human) IRDFNTNKCKGFGFV K310
HuR (mouse) IRDFNTNkCKGFGFV K283-ub
HuR (rat) IRDFNTNKCKGFGFV K283
S304-p
EAAMAIAsLNGYRLG
Upstream
Downstream
1 0
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • protein degradation
Putative in vivo kinases:
  • IKKA (human)
Treatment
  • CG-5
HuR (human) EAAMAIAsLNGYRLG S304-p
HuR iso2 (human) EAAMAIASLNGYRLG S331
HuR (mouse) EAAMAIASLNGYRLG S304
HuR (rat) EAAMAIASLNGYRLG S304
K313-ub
NGYRLGDkILQVsFk
Upstream
Downstream
1 11
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • RNA stability, inhibited
Treatment
  • MG132
HuR (human) NGYRLGDkILQVsFk K313-ub
HuR iso2 (human) NGYRLGDKILQVSFK K340
HuR (mouse) NGYRLGDKILQVsFk K313
HuR (rat) NGYRLGDKILQVSFK K313
S318-p
GDkILQVsFkTNkSH
Upstream
Downstream
8 3
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • protein degradation
Effects on Biological Processes:
  • apoptosis, induced
  • carcinogenesis, altered
  • cell cycle regulation
  • cell motility, altered
Kinase, in vitro:
  • PKCD (human)
Putative in vivo kinases:
  • PKCA (human)
  • PKCD (human)
Treatment
  • adriamycin
  • angiotensin_2
  • CG-5
  • rottlerin
  • siRNA
HuR (human) GDkILQVsFkTNkSH S318-p
HuR iso2 (human) GDKILQVSFKTNKSH S345
HuR (mouse) GDKILQVsFkTNkSH S318-p
HuR (rat) GDKILQVSFKTNKSH S318
K320-ac
kILQVsFkTNkSHk_
0 1
HuR (human) kILQVsFkTNkSHk_ K320-ac
HuR iso2 (human) KILQVSFKTNKSHK_ K347
HuR (mouse) KILQVsFKTNkSHK_ K320
HuR (rat) KILQVSFKTNKSHK_ K320
K320-ub
kILQVsFkTNkSHk_
0 44
HuR (human) kILQVsFkTNkSHk_ K320-ub
HuR iso2 (human) KILQVSFKTNKSHK_ K347
HuR (mouse) KILQVsFkTNkSHK_ K320-ub
HuR (rat) KILQVSFKTNKSHK_ K320
K320-m1
kILQVsFkTNkSHk_
0 1
HuR (human) kILQVsFkTNkSHk_ K320-m1
HuR iso2 (human) KILQVSFKTNKSHK_ K347
HuR (mouse) KILQVsFKTNkSHK_ K320
HuR (rat) KILQVSFKTNKSHK_ K320
K323-ub
QVsFkTNkSHk____
0 2
HuR (human) QVsFkTNkSHk____ K323-ub
HuR iso2 (human) QVSFKTNKSHK____ K350
HuR (mouse) QVsFkTNkSHK____ K323-ub
HuR (rat) QVSFKTNKSHK____ K323
K326-ub
FkTNkSHk_______
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • RNA stability, inhibited
HuR (human) FkTNkSHk_______ K326-ub
HuR iso2 (human) FKTNKSHK_______ K353
HuR (mouse) FkTNkSHK_______ K326
HuR (rat) FKTNKSHK_______ K326